HOME/INDUSTRIES/Healthcare & Life Sciences
SECTOR PRACTICE · HEALTHCARE & LIFE SCIENCES

EU compliance for healthcare & life sciences

GDPR, NIS2, and cybersecurity for hospitals, pharma, medical devices, and research

REGULATIONS.STACK · HEALTH● 09
GDPRSpecial-category health data
NIS2Hospitals as essential entities
AI ACTMedical AI and diagnostic tools
MDRMedical Device Regulation
IVDRIn-Vitro Diagnostic Regulation
CTRClinical Trials Regulation
EHDSEuropean Health Data Space
GMPGood Manufacturing Practice
EIDASeID for patient services
FREE 30-MIN CONSULTATION

Talk to a senior advisor.

One business day reply. Clear next steps and indicative pricing.

1 BUSINESS DAY REPLYNDA ON REQUESTNO OBLIGATION
01 / WHO WE SERVE

Six healthcare profiles, one compliance map.

From single-site clinics to multinational pharma. The regulatory load changes with patient volume, data sensitivity and product type.

HOSPITALS

Hospitals & clinics

Patient records, breach reporting, AZOP and BfArM liaison.

GDPRNIS2EHDS
PHARMA

Pharmaceutical companies

Clinical trial data, pharmacovigilance, supply-chain integrity.

GDPRCTRGMP
MEDICAL DEVICES

Medical device manufacturers

MDR/IVDR conformity, post-market surveillance, software as MD.

MDRIVDRGDPR
DIGITAL HEALTH

Digital health & telemedicine

GDPR for health apps, AI Act for diagnostic AI, EHDS interoperability.

GDPRAI ACTEHDS
BIOTECH

Biotech & research labs

Genomic data, research ethics, cross-border data sharing.

GDPRCTREHDS
DIAGNOSTICS

Diagnostic laboratories

IVDR conformity, AI-assisted diagnostics, accreditation regimes.

IVDRAI ACTGDPR
02 / LANDSCAPE

The healthcare regulatory clock.

Eight regimes interlock. We sequence them around your release cadence.

LIVEGDPR
IN FORCE

Health data special category

Article 9 lawful basis, DPIA mandatory, breach reporting in 72h, patient rights at scale.

LIVEMDR
IN FORCE

Medical Device Regulation

Conformity assessment, CE marking, post-market surveillance, vigilance reporting.

LIVEIVDR
IN FORCE

In-Vitro Diagnostic Regulation

Risk classification, notified body involvement for higher classes, technical documentation.

LIVENIS2
IN FORCE

Healthcare as essential entity

Risk management, 24h/72h incident reporting, supply-chain security, board accountability.

NEXTEHDS
MAR 2026

European Health Data Space

Patient access to own data, secondary use of health data for research, interoperability obligations.

CRITICALAI ACT
AUG 2026

High-risk medical AI

Annex III medical AI: conformity assessment, technical documentation, human oversight, post-market monitoring.

NEXTCTR
ROLLING

Clinical Trials Regulation

EU Clinical Trials Information System (CTIS), centralised submission, public transparency.

PLANNEDEPRIVACY
TBD

ePrivacy Regulation

Stricter consent for cookies, marketing and metadata. Replaces national rules.

03 / WHAT TO SOLVE

Where healthcare organisations get stuck.

01

Special-category data at scale

Article 9 health data needs explicit consent or another lawful basis. DPIAs are mandatory. Pseudonymisation rarely fits clinical workflows.

IMPACTAZOP and BfDI fines starting in low six figures.
02

MDR / IVDR documentation backlog

Notified bodies are overloaded. Conformity assessment timelines stretched to 18+ months for some classes.

IMPACTProduct market entry delayed past commercial windows.
03

AI Act applies to diagnostic AI

Annex III lists medical AI as high-risk. Conformity, technical file, human oversight, post-market monitoring all required.

IMPACTMis-classified AI faces market withdrawal.
04

NIS2 hospital classification

Hospitals fall under essential entity scope. Cyber-attacks on healthcare have doubled since 2022.

IMPACTBoard members personally named in supervisory letters.
05

Cross-border clinical trial data

EU Clinical Trials Regulation centralised submission, but data flows still hit Schrems II issues for US sponsors.

IMPACTTransfer impact assessments per protocol amendment.
06

EHDS readiness for secondary use

Patient data must be made available for research with safeguards. Anonymisation standards still being defined.

IMPACTNon-compliance triggers Health Data Access Body action.
04 / OFFERING

Our services for healthcare

HX-01

GDPR programme for healthcare

Article 9 mapping, patient rights workflow, DPIA library, breach response, AZOP and BfDI liaison.

DArt. 9 mappingDDPIA libraryDAZOP/BfDI liaison
HX-02

MDR / IVDR conformity support

Technical documentation, risk management (ISO 14971), notified body submissions, post-market surveillance.

DTech fileDPMS planDNB liaison
HX-03

Medical AI (AI Act + MDR overlap)

Combined AI Act and MDR conformity, technical file (Annex IV), human oversight, post-market monitoring.

DAnnex IVDHuman oversightDPMM
HX-04

NIS2 for hospitals and pharma

Entity classification, ISMS build, supply-chain assurance, 24h/72h reporting playbook.

DGap reportDISMSDIncident SOP
HX-05

Clinical trial compliance

CTR Article 81 transparency, CTIS submissions, data flow mapping, transfer impact assessments.

DCTIS supportDTransparencyDTIA
HX-06

EHDS readiness

Data interoperability, secondary-use governance, Health Data Access Body engagement.

DEHDS gapDGovernanceDHDAB liaison
HX-07

Pharmacovigilance and ICSR

ICSR data handling, signal management, EudraVigilance integration, GxP-aligned data governance.

DICSR opsDSignal managementDEV
HX-08

Telemedicine and digital health

Health-app GDPR programme, cross-border telemedicine, patient consent workflows.

DApp GDPRDCross-borderDConsent
HX-09

Outsourced healthcare DPO

Senior DPO with healthcare experience, named to AZOP / BfDI, board reporting, DSAR handling.

DDPO contractDDSAR opsDBoard memos
05 / SELECTED WORK

Healthcare engagements.

All case studies →
CASE 01EU hospital group

GDPR + NIS2 programme across 9 hospitals. AZOP audit closed with zero findings.

9
HOSPITALS
1.4M
PATIENTS
0
FINDINGS
SCOPEGDPR · NIS2 · ISO 27001 · Breach response
CASE 02Medical device SaaS

MDR + AI Act conformity for AI-assisted diagnostic platform. CE marking obtained.

IIa
CLASS
11 mo
NB CYCLE
Granted
CE
SCOPEMDR · AI Act · ISO 13485 · Technical file
CASE 03Multi-country CRO

Clinical Trials Regulation programme rolled across 12 EU member states.

27
PROTOCOLS
12
STATES
Live
CTIS
SCOPECTR · CTIS · Pharmacovigilance · GxP
06 / FREE TOOL

Map your healthcare stack to the EU rulebook.

Eight questions about your patient base, products and data flows. Get an indicative obligations map across GDPR, MDR, IVDR, NIS2, AI Act and EHDS.

Run obligations mapper~ 4 MIN
MAPPER.PREVIEWSTEP 4 / 8
Does your product or service handle patient health data in the EU?
Yes, direct patient care or clinical recordsA
Yes, research or trial data (pseudonymised)B
Indirect, payer or admin data onlyC
No patient dataD
INDICATIVE → GDPR ART. 9 + NIS2 ART. 21
07 / FAQ

Frequently Asked Questions

01Are we in scope for NIS2 as a hospital?+

Yes. NIS2 Annex I explicitly lists healthcare providers as essential entities. Risk-management measures, 24h early-warning and 72h incident notification apply. Board members carry personal accountability.

02How does the AI Act apply to our medical AI?+

If your AI is intended for medical purposes under MDR, it is classified as high-risk under Annex III. You need conformity assessment, technical documentation (Annex IV), human oversight and post-market monitoring on top of MDR obligations.

03Can MDR and AI Act conformity be combined?+

Yes. We build a combined technical file that satisfies both regimes. The Commission has confirmed alignment between MDR conformity assessment and AI Act conformity, with one notified body sufficient in most cases.

04What is the European Health Data Space?+

EHDS gives patients access to their own health data and creates a secondary-use regime for research. It applies from March 2026 phased through 2031. We help build the governance and interoperability layers.

05Do we need a DPO?+

Healthcare organisations processing patient data at scale almost always need a DPO under Article 37(1)(c) GDPR. We provide a senior DPO with healthcare-specific experience under retainer.

06How are pharma clinical trials affected by GDPR?+

Trial participants are data subjects with GDPR rights. The Clinical Trials Regulation governs consent and transparency, but GDPR adds the data protection layer. Both apply in parallel.

07What about cross-border data transfers?+

Health data transfers outside the EEA require GDPR transfer mechanisms (typically SCCs 2021 plus a transfer impact assessment). Most US-EU healthcare partnerships need supplementary measures.

08Do you work with our existing notified body?+

Yes. We coordinate with your chosen notified body, prepare the technical file, manage queries and run dry-run interviews before submission.

08 / RELATED

Related practices and guides.

09 / GET STARTED

Need EU compliance for your healthcare organization?

Typical outcomes: GDPR roadmap, NIS2 priorities, incident response readiness.